Filing Details
- Accession Number:
- 0001384101-25-000042
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-10 16:43:53
- Reporting Period:
- 2025-03-06
- Filing Date:
- 2025-03-10
- Accepted Time:
- 2025-03-10 16:43:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1991536 | John Leite | 6000 Shoreline Court, Suite 300 South San Francisco CA 94080 | Chief Commercial Officer-Clia | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-06 | 36,240 | $0.00 | 107,660 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2025-03-07 | 2,400 | $31.04 | 105,260 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-07 | 5,011 | $31.96 | 100,249 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Restricted stock units awarded on March 6, 2025 vest 25% on March 2, 2026 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.
- The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 6, 2024.
- Represents weighted average sales price. Sale prices for the transactions range from $30.63 to $31.61. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- Represents weighted average sales price. Sale prices for the transactions range from $31.71 to $32.44. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Billionaire Hedge Funds
